Adicet Bio, Inc.
ACET· Nasdaq
Released Nov 8, 2022, after the close
10-Q filed Nov 8, 2022, 39 days after period end · 0000950170-22-023230
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$22.00M | -$14.01M | -$14.78M | -$14.78M |
| EPS Diluted | -$0.53 | -$0.44 | -$2.84 | -$6.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR